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Autophagy refers to a set of catabolic pathways that together facilitate degradation of superfluous, damaged
and toxic cellular components. The most studied type of autophagy, called macroautophagy, involves
membrane mobilisation, cargo engulfment and trafficking of the newly formed autophagic vesicle to the
recycling organelle, the lysosome. Macroautophagy responds to a variety of intra- and extra-cellular stress
conditions including, but not limited to, pathogen intrusion, oxygen or nutrient starvation, proteotoxic and
organelle stress, and elevation of reactive oxygen species (ROS). ROS are highly reactive oxygen molecules
that can interact with cellular macromolecules (proteins, lipids, nucleic acids) to either modify their activity or,
when released in excess, inflict irreversible damage. Although increased ROS release has long been
recognised for its involvement in macroautophagy activation, the underlying mechanisms and the wider
impact of ROS-mediated macroautophagy stimulation remain incompletely understood.
We therefore discuss the growing body of evidence that describes the variety of mechanisms modulated by
ROS that trigger cytoprotective detoxification via macroautophagy. We outline the role of ROS in signalling
upstream of autophagy initiation, by increased gene expression and post-translational modifications of
transcription factors, and in the formation and nucleation of autophagic vesicles by cysteine modification of
conserved autophagy proteins including ATG4B, ATG7 and ATG3. Furthermore, we review the effect of ROS
on selective forms of macroautophagy, specifically on cargo recognition by autophagy receptor proteins p62
and NBR1 (neighbour of BRCA1) and the recycling of mitochondria (mitophagy), and peroxisomes
(pexophagy). Finally, we highlight both, the standalone and mutual contributions of abnormal ROS signalling
and macroautophagy to the development and progression of neurodegenerative diseases.
© 2020 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).Macroautophagy: A Brief Overview
Macroautophagy, from herein referred to as
autophagy, refers to the dynamic rearrangement of
cellular membranes to engulf cytoplasmic cargo in a
double-membraned compartment (autophagosome)
and its delivery to the lysosome. Autophagy is the
principal degradation system for long-lived proteins
and the only known pathway of whole organelle
recycling [1]. The process is regulated by a family of
core autophagy (ATG) proteins that are largely
conserved from yeast to mammals. In higher
organisms, the core members associate with their
regulators into five functional complexes that initiate: L. Sedlackova, G. Kelly and V. I. Korol
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uthors. Published by Elsevier Ltd. This
ses/by/4.0/).autophagosome formation, cargo docking, vesicle
expansion and closure [1]. Briefly, activation of the
first complex, the unc-51-like autophagy activating
kinase 1 (ULK1) protein kinase complex, initiates the
formation of an isolation membrane, which is
followed by membrane elongation mediated by
delivery of vesicles containing ATG9 [1,2]. Phos-
phatidylinositol 3-phosphate (PI(3)P), a product of
the class III PI(3)-kinase complex, then serves to
recruit the last two autophagy complexes containing
ATG12 and a member of a family of mammalian
ATG8 orthologues (microtubule associated protein 1
light-chain 3 proteins (MAP1LC3A-C/LC3A-C), the
g-aminobutyric acid receptoreassociated proteinchuk, The pROS of Autophagy in Neuronal Health, Journal of
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2 Autophagy in Neuronal Health(GABARAP), and the g-aminobutyric acid recep-
toreassociated protein-like 1 and 2 (GAPARAPL 1/
2)) [3], that undergo ubiquitin-like conjugation and
assist with cargo docking, vesicle formation and
degradation [4]. Of the two known forms of autop-
hagy, basal and induced, we explore the role of
reactive oxygen species (ROS) in the initiation and
regulation of the latter form aimed at cytosol
detoxification and its relevance to the health of the
neuronal systems.Reactive Oxygen Species: The Types,
Sources and Cellular Functions
ROS is a collective term used to describe species
formed as intermediates of dioxygen (O2) reduction
to H2O. In its ground state, the O2 molecule harbours
two unpaired valence electrons and is thus con-
sidered a radical species [5]. However, due to the
parallel spin of its valence electrons and the
nonradical nature of most elements, O2 is unlikely
to participate in biological reactions without first
overcoming the spin restriction [5]. In aerobically
adapted cells, oxygen activation is achieved by its
bonding to transition metals that are capable of
overcoming oxygen's spin restriction by mediating a
series of one-electron reduction reactions via a
sequence of intermediates [6]. The partially reduced
O2 intermediates include the superoxide anion (O2
)
that contains a single unpaired electron, the hydro-
gen peroxide (H2O2) that contains no unpaired
electrons, and the hydroxyl radical (OH) that
contains a single unpaired electron [6]. An unpaired
electron on the outer orbital of O2
 and OH
increases their ability to take part in one-electron
oxidative transfer reactions leading to macromole-
cule modification and, if excessive, damage and loss
of function.
Once thought to only form in large quantities on
ionising radiation, it is now recognised that ROS
escape complete reduction in biologically significant
quantities. ROS toxicity is intensified by O2
 inter-
action with nitrogen monoxide (nitric oxide, NO),
another radical species produced by nitric oxide
synthase (NOS) enzymes as a signalling molecule
important in vasodilation, neurotransmission and
synaptic plasticity [7]. Peroxynitrite anion (ONOO),
a product of NO oxidation by O2
, is a reactive
nitrogen species (RNS) that is capable of altering
cellular signalling by protein modification via forma-
tion of irreversible nitrosyl adducts on tyrosine
residues or reversible oxidative modification of
cysteine, methionine and tryptophan residues [7].
In addition, peroxynitrite can damage macromole-
cules including nucleic acids, proteins and lipids and
initiate various forms of cell death [8]. Although
largely regarded as detrimental to cellular health,
ROS have been rebranded from villains to signalPlease cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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and increase health span and longevity [9].Redox Regulation of Autophagy
The balance between beneficial and deleterious
roles of ROS is heavily dependent on the efficiency
of cellular detoxification systems. Cellular redox
homeostasis is maintained by a defence system of
endogenous enzymatic (e.g. superoxide dismutases
(SODs), catalase, glutathione peroxidase (GPx),
glutathione reductase (GRx), thioredoxins and per-
oxiredoxins) and nonenzymatic ROS scavengers
(e.g. glutathione (GSH), coenzyme Q, vitamins C
and E) [10]. This first line of defence scavenges and
detoxifies ROS and thus prevents the propagation of
ROS signalling. However, large bursts of localised
ROS can overwhelm the endogenous antioxidant
systems and promote ROS signalling, or when in
excess, confer oxidative damage on cellular macro-
molecules. The second line of defence comprises
systems that remove and recycle oxidised cytotoxic
macromolecules [11]. Cells rely primarily on the
proteasome- and autophagy-mediated clearance of
oxidised cargo. Studies focussing on the role of the
proteasome in oxidised protein recycling reveal a
link between oxidation and increased activity of the
proteasome [12]. ROS-mediated dissociation of the
26S proteasome into its 19S (regulatory complex)
and 20S (catalytic core) components removes the
20S-mediated specificity for ubiquitylated substrates
and thus promotes rapid recycling of oxidised
proteins [12,13]. In addition, exposure to elevated
ROS was also linked to increased proteasome
synthesis [14,15]. However, the limited functionality
of the proteasome capable of degrading primarily
short-lived nonaggregated proteins suggests that
the main catabolic pathway that partakes in cellular
detoxification by sequestration and clearance of
oxidised cargo is autophagy.
Similar to the response of the proteasome,
autophagy stimulation by ROS was observed on
cell treatment with H2O2 and nutrient starvation
experiments, in which increase in H2O2 release
correlated with autophagosome formation [16]. A
later study by Gibson group demonstrated that
prolonged withdrawal of glucose, L-glutamine, pyr-
uvate and serum or all amino acids and serum, led to
increased release of O2
, while amino acid starva-
tion also increased cellular levels of H2O2 [17].
Importantly, increased stimulation of autophagy flux
correlated with O2
, but not with H2O2 species. An
unexpected finding of the study revealed that
addition of exogenous H2O2, used in multiple in
vitro studies to mimic endogenous ROS release,
stimulated O2
 release that in turn initiated autop-
hagosome formation. Altogether, these findings
support the notion that endogenous ROSchuk, The pROS of Autophagy in Neuronal Health, Journal of
3Autophagy in Neuronal Healthrelease and exogenous H2O2 supplementation are
sufficient drivers of the autophagy pathway. Here,
we explore the mechanisms by which proteins sense
increased levels of cellular oxidative stress, upregu-
late levels of autophagy components, enhance
autophagy efficiency and altogether recycle not
only the cellular macromolecules damaged by
ROS, but also the organelles that release ROS in
the first place (Table 1).
Transcriptional regulation of autophagy
Transcriptional upregulation of key autophagy
genes in response to various nutritional stresses
depends on several transcription factors (TFs)
including transcription factor EB (TFEB), forkhead
box O (FoxO), early growth response (EGR-1), E2F
transcription 1 (E2F1), Jun and farnesoid X receptor
(FXR) (summarised in Ref. [18]). It is currently not
known whether direct interaction with ROS or
oxidative post-translational modifications (PTMs)
have an effect on the activity or localisation of most
of these factors, but some direct and indirect links
between ROS and upstream regulators of TF activity
or localisation have been described.
TFEB belongs to a microphthalmia family of bHLH-
LZ transcription factors (Mit/TFE) that play a crucial
role in autophagy stimulation and lysosomal biogen-
esis [19]. TFEB function as a master regulator of
lysosomal biogenesis that occurs via positive stimu-
lation of the coordinated lysosomal expression and
regulation (CLEAR) network of genes [20]. In
addition to regulation of lysosome biogenesis, an in
vitro TFEB overexpression (OE) study identified
multiple autophagy genes that were consistently and
significantly upregulated in various OE models
including ATG4D, ATG9B, LC3B and SQSTM1/p62
[21]. A link between TFEB activity and intracellular
ROS was reported from models of starvation [22] or
exogenous and endogenous increase in ROS levels
[23]. In both studies, authors observed activation of
an indiscriminate lysosomal cation channel, muco-
lipin 1 (MCOLN1/TRPML1) that led to Ca2þ influx
into the cytoplasm and stimulated calcineurin phos-Table 1. Redox-sensitive proteins in autophagy.
Protein Function in autophagy
machinery
Redox-Sensitive Cys
residues
MCOLN1 Indirect not identified Ca
[2
KEAP1 Indirect multiple NR
p62 Selective cargo recognition Cys105 and Cys113 Ol
ATG3 Autophagosome elongation Cys264 Lo
ATG4B Pro-LC3 processing,
LC3-PE deconjugation
Cys74 or Cys78 Lo
[1
ATG7 Autophagosome elongation Cys572 Lo
ATM Indirect Cys2991 A
pe
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to its translocation into the nucleus followed by
increased autophagy flux (Fig. 1A) [22,23]. More-
over, authors of a recently published study demon-
strated that TFEB and other members of the Mit/TFE
family (transcription factor E3 (TFE3) and micro-
phthalmia-associated transcription factor (MITF))
are sensitive to ROS-mediated activation [24]. In
this study, oxidation of the only Cys residue in TFEB,
Cys212, led to loss of TFEB phosphorylation, its rapid
(within 8 min) translocation to the nucleus and
increased TFEB/TFE3/MITF-dependent transcrip-
tion of the CLEAR genes, some autophagy genes
and, interestingly, MCOLN1 [24].
At the same time, evidence of a clear link
between ROS and activation of FoxO, Jun, EGR-
1, E2F1 and FXR TFs, all of which regulate
transcription of multiple autophagy genes [18],
remains limited. A link between ROS and FoxO
family members focuses on the modulation of FoxO
activity and localisation due to a) phosphorylation
events of upstream receptor tyrosine kinases; b)
acetylation status regulated by upstream acetyl-
transferases and deacetylases; and c) FoxO ubi-
quitylation (reviewed in Refs. [25,26]). The
strongest link between cellular redox status, FoxO
activation and autophagy stimulation comes from
studies of sirtuin (SIRT)-mediated deacetylation of
FoxO1 and FoxO3 isoforms that are well estab-
lished as inducers of autophagy [26]. Although
SIRT1 and SIRT3 were shown to activate FoxO1
and FoxO3 in response to various stresses
[27e30], and both SIRTs are indirectly activated
by ROS, unequivocal evidence of a ROS-SIRT-
FoxO-autophagy axis is not yet available. Similarly,
gene expression, protein levels and nuclear locali-
sation of the EGR-1 transcription factor all increase
on cell stimulation with H2O2 in a JNK (c-Jun NH2
terminal kinase)- and ERK (the extracellular signal-
regulated kinases)-dependent manner [31]. Impor-
tantly, stimulation of EGR-1 activity by ionising
radiation was shown to increase expression of the
ATG4B protein and initiate prosurvival autophagy
[32]. Finally, there is currently no indication of ROS-Outcome of Oxidation Autophagy Outcome
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Figure 1. Autophagy regulation by ROS. Increased presence of ROS affects autophagymechanisms via modification
of multiple proteins involved in autophagy regulation. (A) Oxidative modification of MCOLN1 releases lysosomal Ca2þ
stores that via calcineurin phosphatase activity, promote TFEB nuclear localisation and transcriptional activity of lysosomal
and ATG genes. (B) ROS has a dual role in regulating autophagosome formation. First, oxidation of residues near the
catalytic core of ATG4 reportedly inhibits its deconjugating activity and results in increased autophagic flux. Second, ATG7
and ATG3 activity is inhibited by oxidation-dependent ATG7-ATG3 heterodimer formation on LC3 depletion. (C) KEAP1-
NRF2 heterodimer is disrupted either by KEAP1 oxidative modification or by increased p62 binding. Liberated NRF2 that
escapes degradation and cytoplasmic sequestration initiates a positive feedback loop of NRF2 and p62 expression.
Intermolecular cysteine bond formation of p62 also stimulates autophagy flux. (D, E) Selective recycling of mitochondria
(mitophagy) and peroxisomes (pexophagy) is enhanced by ROS. (D) Transient bursts of ROS trigger mPTP opening,
localised depolarisation and PINK1 stabilisation at the OMM (D1). Mitophagy is initiated by Parkin recruitment, OMM
protein ubiquitylation (Ub) and recognition by autophagy receptor proteins. Mitochondrial lipid peroxidation triggers CL
externalisation and LC3 docking (D2). Elevated intracellular ROS levels promote stabilisation and transcriptional activity of
HIF-1 (D3). Increased levels of BNIP3 and NIX dock on OMM and promote mitochondrial recycling by directly interacting
with LC3. Selective labelling of oxidised or superfluous organelles triggers mitophagy. (E) ROS-activated ATM localisation
to peroxisomes results in PEX5 phosphorylation, ubiquitylation and autophagy receptor recruitment. Selective autophagy
of ROS-producing organelles decreases intracellular ROS levels and restores homeostasis.
4 Autophagy in Neuronal Healthmediated regulation of either E2F1 or FXR tran-
scription activity.
In summary, multiple transcription factors are
involved in autophagy regulation during adaptation
to a variety of cellular stresses. The extent and in
vivo relevance of ROS-mediated stimulation of
signalling cascades upstream of TF activation is
not known and requires further enquiry. The stron-
gest link between ROS and TF activation has so far
been demonstrated in TFEB activation. Direct
oxidation of TFEB Cys212 and indirect MCOLN1-
Ca2þ-calcineurin cascade-mediated TFEB depho-
sphorylation promotes its translocation to thePlease cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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esis and expression of several core autophagy
proteins involved in autophagosome expansion
(ATG4B, ATG9B, LC3B), autophagosome matura-
tion (LC3B) and selective cargo recognition (p62)
[22,23].
Regulation of autophagy initiation
Synthesis of a membrane-bound form of ATG8 on
nascent and maturing autophagosomes is crucial for
autophagy progression and cargo recruitment [33].
Attachment of ATG8 proteins to autophagosomechuk, The pROS of Autophagy in Neuronal Health, Journal of
5Autophagy in Neuronal Healthmembranes is achieved by a covalent bond linkage
between ATG8 and phosphatidylethanolamine (PE).
Formation of the ATG8-PE conjugate is assisted by
three classes of enzymes that sequentially activate
(E1-like enzyme), conjugate (E2-like enzyme) and
ligate (E3-like enzyme) two substrates in a manner
similar to the ubiquitylation pathway [34]. Formation
of ATG8-PE is first potentiated by a pro-ATG8 C-
terminal processing by ATG4 (A-D) and then
mediated by the conjugation system consisting of
ATG7 (E1), ATG3 (E2) and the ATG5-ATG12
conjugate (E3) [1,35]. Similarly, the ATG5-ATG12
conjugate formation is assisted by ATG7 (E1) and
ATG10 (E2) enzymes in an E3-independent process
[36] (Fig. 1B).
Evidence first reported in 2007 and followed up by
the most recent report in 2018 suggests that several
members of core autophagy machinery are regu-
lated by cellular redox state by disulphide bond
formation and oxidative amino acid residue modifi-
cation [16,37]. First, members of the ATG4 family
function as cysteine (Cys)-dependent proteases and
mediate the initial step of ATG8 conjugation to PE by
exposing a conserved C-terminal glycine residue of
ATG8 by proteolytic cleavage of the downstream C-
terminal region [38]. Moreover, ATG4 also acts to
hydrolyse LC3-PE conjugates from the nascent
autophagosome that is crucial for correct substrate
localisation into autophagosomal lumen. Studies of
yeast and human ATG4 homologues involved in
ATG8 processing report that the catalytic activity of
ATG4 is suppressed by oxidative stress. First
reported from human cells, the deconjugating
activity, but not the LC3 processing activity of
ATG4B is rapidly inactivated by a dithiothreitol
(DTT)-sensitive oxidative modification of either the
catalytic (Cys74) or a neighbouring (Cys78) cysteine
residue [16]. Evidence from yeast indicates that
formation of a disulphide bond between noncatalytic
residues (Cys338 and Cys394) suppresses Atg4
activity [39]. Interestingly, both studies report that
oxidative inhibition of ATG4 enzymatic activity
increases autophagosome formation, although the
underlying mechanism of this effect is not fully
understood.
Similarly, direct oxidation of catalytic Cys residues
was recently reported to play a role in the inhibition of
ATG7 and ATG3 activity [37]. The E1-like (ATG7)
and E2-like (ATG3) enzymes of the LC3-PE and
ATG5-ATG12 conjugation systems were found to
associate with LC3A and LC3B by the formation of a
reversible thioester bond that was lost after autop-
hagy induction by amino acid starvation [37]. LC3-
free ATG7 and ATG3 were then prone to H2O2-
mediated redox regulation by the formation of an
intermolecular disulphide bond between the ATG3
and ATG7 catalytic thiols (Cys264 and Cys572,
respectively) that led to impaired LC3-PE conjuga-
tion and the loss of autophagy flux. Interestingly,Please cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
Molecular Biology, https://doi.org/10.1016/j.jmb.2020.01.020owing to the shielding of their cysteine residues, the
LC3-ATG7 and LC3-ATG3 complexes were resis-
tant to oxidation-mediated ATG7-ATG3 disulphide
dimer formation [37].
Collectively, these data suggest a mechanism by
which oxidation of the core autophagy machinery
increases mature autophagosome formation by
inhibiting the hydrolysing activity of ATG4B [16]. In
addition, recent evidence suggests a self-regulatory
mechanism by which the ATG8/LC3-PE formation
and increased autophagy flux mediated by ROS are
inhibited by ATG3-ATG7 disulphide heterodimer
formation on depletion of intracellular ATG8/LC3
pools [37]. In healthy, nonstarved cells, this mechan-
ism would lead to a regulated and rapid clearance of
oxidised cargo. However, it is becoming increasingly
clear that chronic exposure to ROS or concurrent
starvation could derail this system and lead to
autophagy impairment due to loss of ATG8/LC3-
PE conjugation.
Regulation of cargo recognition
Recruitment of the autophagic machinery to its
cargo is mediated by autophagy receptor proteins
[33]. Autophagy receptors are proteins that fulfil
three requirements: direct interaction with LC3 via an
LC3-interacting region (LIR), substrate binding (i.e.
through a ubiquitin binding domain), and an inherent
ability to polymerise or aggregate [33]. The first
discovered and best-characterised selective autop-
hagy receptor, p62 (also known as sequestosome 1
(SQSTM1)), was found to participate in the degrada-
tion of bacterial and viral pathogens, protein aggre-
gates, mitochondria, peroxisomes and secretory
granules (summarised in Ref. [33]). High-order
structure formation of p62 (i.e. multimer, oligomer,
aggregate) is key to its function as an autophagy
receptor [40]. p62 contains several functional
domains interlinked by unstructured regions. Of the
structured domains, the N-terminal PB1 (Phox and
Bem1p), ZZ (ZZ-type zinc finger), and the C-terminal
UBA (ubiquitin associated) [41,42] domains feature
in the context-dependent p62 high-molecular weight
species formation and phase separation. For exam-
ple, PB1 domain of p62 promotes its oligomerisation
via electrostatic PB1-PB1 interactions and facilitates
cargo condensation before enclosure within an
autophagosome [43].
By contrast, an unstructured region between the
PB1 and ZZ domains (also referred to as a
regulatory linker region or an electrostatic PB1
bridge [44,45]), and the ZZ domain itself, contain
cysteine residues that can contribute to p62 oligo-
merisation mediated by the covalent disulphide bond
linkage [46,47]. Intermolecular disulphide bond
formation was found to be crucial for p62 aggrega-
tion and p62-LC3 interaction in response to Nt-Arg
(N-terminal arginine of arginylated substrates)chuk, The pROS of Autophagy in Neuronal Health, Journal of
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these studies hypothesised that it is the conforma-
tional change triggered by Nt-Arg binding that
induces p62 oligomerisation which facilitates further
interactions with autophagy machinery through its
PB1 and LIR domains. The formation of disulphide
bonds observed in p62 upon Nt-Arg binding to the ZZ
domain [46] points towards the role of ROS in the
process of Cys oxidation and p62 oligomerisation in
response to Nt-Arg, although the source of these
ROS had not been investigated. Interestingly, one
cysteine residue in p62 that appears to be involved in
the formation of intermolecular disulphide bonds in
response to Nt-Arg is Cys113 located in the
regulatory linker region [46]. Although the identity
of other cysteine residue(s) required for the forma-
tion of p62 chains remains unknown, Cys113
together with Cys105 has been implicated in the
ability of p62 to sense cellular redox status.
Specifically, in response to elevated ROS levels
redox-sensitive cysteine residues Cys105 and Cys-
113 have been suggested to form intermolecular
disulphide bonds, assist p62 oligomer assembly and
activation of prosurvival autophagy in response to
oxidative stress [47,50]. Altogether, the ability of p62
to become oxidised and form disulphide bonds
appears to be essential for the upregulation of
autophagy in response to proteotoxic or oxidative
stress.
In addition to its structure and multimer formation,
oxidative stress regulates p62 protein levels via its
transcriptional regulation by the nuclear factor
erythroid 2-related factor (NRF2), a master regulator
of the cellular antioxidant response (Fig. 1C). In
basal conditions, NRF2 associates with a homo-
dimer of its binding partner, Kelch-like ECH-asso-
ciated protein 1 (KEAP1) [51,52], and undergoes
rapid ubiquitylation and proteasomal degradation.
Elevation of intracellular ROS levels leads to
oxidation of Cys residues and subsequent disul-
phide bond formation and conformational changes in
KEAP1 that ultimately result in the release of NRF2
and its translocation to the nucleus [53]. Once inside
the nucleus, NRF2 initiates transcription of genes
that contain an antioxidant response element (ARE)
in their promoter [54]. Among the over 600 genes
that are targets of NRF2 are several core ATG
proteins, selective autophagy receptors and, impor-
tantly, NRF2 and p62 themselves [54e56]. Further-
more, via its interaction with KEAP1, p62 disrupts
one of KEAP1 binding sites with NRF2 and thus
inhibits NRF2 degradation [55,57,58]. Therefore,
elevation of intracellular oxidative stress leads to
the establishment of a p62-KEAP1-NRF2-ARE feed-
forward loop that, among other pathways, stimulates
autophagy and leads to detoxification of the
damaged cytoplasmic contents (Fig. 1C). This loop
is broken on ROS detoxification, p62 recycling and
NRF2-KEAP1 heterodimer formation.Please cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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selective autophagy receptor, the neighbour of
BRCA1 (NBR1) [33], it is highly likely that the
redox-sensitivity may not be unique to p62. Indeed,
data from Komatsu group demonstrates that NBR1
is transcriptionally upregulated in response to treat-
ment with a strong oxidant, sodium arsenite [59].
NBR1 has so far been identified for its involvement in
selective autophagy pathways that degrade protein
aggregates and peroxisomes [33] and it will be
interesting to see whether cellular ROS can regulate
these processes via direct NBR1 oxidation.
Regulation of selective organelle degradation
In healthy cells, most intracellular endogenous
ROS are released as by-products of energy genera-
tion from macronutrients including glucose (in
mitochondria) and fatty acids (in mitochondria and
peroxisomes). At low levels, ROS act as messen-
gers that communicate the metabolic status to
cytoplasmic components and regulate cellular adap-
tation to metabolic stresses [60]. However, dysfunc-
tion of either organelle can lead to pathological ROS
production that can overwhelm organellar and
cytoplasmic antioxidant defences. It could be
hypothesised that in this case, oxidative modification
of redox-sensitive sentinels may promote recruit-
ment of autophagic machinery to the site of damage
to catabolise the source of ROS and protect the cell
from further damage.
Mitophagy refers to the selective degradation of
mitochondria, a network of double-membraned
organelles that act as hubs of cellular energy
production, signalling and viability [61]. Three
distinct pathways can mediate ROS-induced mito-
phagy (Fig. 1D). First, ROS trigger an indirect
mechanism whereby a pathological burst of ROS
within a dysfunctional mitochondrion can trigger
opening of a mitochondrial permeability transition
pore (mPTP) [62,63]. mPTP is a nonselective
voltage-dependent channel that releases small
solutes across the inner mitochondrial membrane
(IMM) and collapses the electro-chemical gradient
achieved by proton (Hþ) pumping by the electron
transport chain [63]. Loss of mitochondrial mem-
brane potential leads to the inhibition of mitochon-
drial protein import pores and thus promotes
stabilisation and activation of PTEN-induced puta-
tive kinase 1 (PINK1) on the outer mitochondrial
membrane [64]. Activity of the PINK1-Parkin-ubiqui-
tin axis leads to dysfunctional organelle recognition
by autophagy receptors and recruitment of the
autophagic machinery [65].
Second, ROS released within the mitochondrial
matrix promote oxidative modification of cardiolipins
(CL), an abundant family of mitochondria-specific
phospholipids located predominantly in the inner
leaflet of the IMM. Within healthy mitochondria, CLchuk, The pROS of Autophagy in Neuronal Health, Journal of
7Autophagy in Neuronal Healthfunctions to stabilise mitochondrial electron transport
chain complex and supercomplex assembly and
promote ETC activity (reviewed in Ref. [66]). How-
ever, increase in mitochondrial ROS release was
shown to promote human phospholipid scramblase-
3 (PLS3)-assisted CL translocation from the IMM to
the outer leaflet of the outer mitochondrial mem-
brane (OMM) [67]. Supported by computational
modelling and experimental evidence, externalised
CL was demonstrated to act as a receptor for
mitophagy due to its interaction with the N-terminus
of LC3 and selective recognition of dysfunctional
organelles [67]. Although the specific stimuli and
mechanisms of CL oxidation in vivo remain elusive,
an extensive review by Yin and Zhu provides
evidence for oxidative modification of CL by different
ROS, including OH and H2O2, leading to the
formation of numerous oxidation products with
unknown physiological roles that require further
characterisation [68].
Finally, the involvement of ROS in the initiation of a
well-characterised hypoxia-induced mitophagy is a
topic of much controversy. The canonical pathway is
regulated by hypoxia-inducible factor-1 (HIF-1), a
heterodimeric transcription factor that is stabilised in
low oxygen conditions due to the loss of upstream
degradation signalling [69]. Stabilised HIF-1, formed
as a dimer of O2-sensitive HIF-1a and constitutive
HIF-1b subunits, then binds to hypoxia response
elements (HREs) in the promoter regions of non-
coding RNAs and proteins that regulate autophagy,
angiogenesis, cellular metabolism and apoptosis
[70,71]. Two proteins that fall under the transcrip-
tional regulation of HIF-1 are BNIP3 and NIX,
noncanonical BCL-2 family proteins that interact
with BCL-2 to release Beclin 1 from a BCL-2-Beclin 1
heterodimer and allow Beclin 1 association with the
Class III PI(3)-kinase complex [61,70,72]. Moreover,
BNIP3 and NIX contain a transmembrane glycine
zipper domain that promotes their dimerisation and
insertion into OMM [73,74]. Both proteins also
physically interact with LC3 [75,76] and recruit the
autophagic machinery to superfluous mitochondria,
promote mitochondrial recycling and altogether
decrease mitochondrial ROS production. Although
initially described for their role in hypoxia, an
increasing body of contradictory evidence
addresses whether ROS can directly and indirectly
promote HIF-1 stabilisation (discussed in Ref. [77]).
Despite the described controversy in the topic of
HIF-1 ROS-induced stabilisation on mitochondria,
the literature agrees that exogenous addition of ROS
or inhibition of superoxide dismutases promote HIF-
1 stabilisation under normal oxygen conditions [77],
which may be sufficient for mitochondrial removal by
BNIP3 and NIX. However, more needs to be
understood about the mechanism of HIF-1 stabilisa-
tion, and BNIP3 and NIX targeting specifically to
ROS-producing organelles.Please cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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release ROS as a by-product of long-chain fatty acid
b-oxidation. In contrast to mitochondria which
transfer liberated electrons to the ETC, electron
release during b-oxidation in peroxisomes results in
uncontrolled O2 reduction to H2O2 [78]. In addition,
several other mechanisms of O2
 production were
identified, including the activity of xanthine oxidase
and systems on the peroxisomal membrane that use
reduced nicotinamide adenine dinucleotide (NADH)
and reduced phosphorylated NAD (NADPH) as
electron donors (reviewed in Ref. [79]). Localised
ROS release from peroxisomes triggers organelle
recycling in an Ataxia-telangiectasia mutated (ATM)
kinase-dependent manner. In addition to its role as a
DNA damage sensor in the nucleus, ATM was also
found to colocalise with the outer surface of the
peroxisomal membrane via its interaction with
peroxin 5 (PEX5), a peroxisome import receptor
(Fig. 1E) [80]. Although the physiological role of ATM
interaction with PEX5 in basal conditions is
unknown, it was previously reported that ATM kinase
activity is enhanced by an intermolecular Cys2991-
dependent disulphide bond formation [81]. Conse-
quently, exogenous H2O2 addition into culture media
of a cellular model promoted ATM colocalisation with
PEX5 and led to phosphorylation of PEX5 serine 141
(Ser141) residue that primed PEX5 for subsequent
lysine 209 (Lys209) monoubiquitylation [80]. In turn,
PEX5 monoubiquitylation was shown to recruit
NBR1 (and p62) and, by extension, the autophagic
machinery and thus stimulate pexophagy (Fig. 1E)
[82e84]. In addition to its direct interaction with
PEX5, H2O2-activated ATM also promoted a phos-
phorylation cascade of the ATM-tuberous sclerosis
complex 2 (TSC2) mammalian target of rapamycin
complex 1 (mTORC1) axis that repressed mTORC1
activity and stimulated autophagy [80]. Altogether,
pexophagy is stimulated by ROS in a redox-sensitive
ATM-dependent manner that promotes autophagy
initiation downstream of mTORC1 inhibition and
select ive peroxisome target ing via PEX5
ubiquitylation.ROS and Autophagy in Neuronal Health
The central nervous system (CNS) is uniquely
sensitive to oxidative stress due to its anatomical
and functional features. The low rate of neuronal
regeneration, the exceptionally high demand for
energy, the high lipid content, the high concentration
of NO and the low level of antioxidant defences
result in an increased vulnerability of the brain to
elevated ROS levels [85]. CNS vulnerability to age-
related decline can result in a range of sporadic
neurodegenerative disorders. This heterogeneous
group of disorders greatly varies with regards to the
age of onset, brain regions affected by pathology,chuk, The pROS of Autophagy in Neuronal Health, Journal of
8 Autophagy in Neuronal Healthsymptoms and is likely to arise as a result of multiple
and variable causes [86]. Molecular disruption in
neurodegenerative disorders commonly includes
increased oxidative stress, mitochondrial dysfunc-
tion, the presence of abnormal protein aggregates
and aberrant proteostasis [87].
ROS in neuronal health and neurodegeneration
ROS act as signal messengers in a healthy brain.
Their generation and diffusion help propagate
signalling cascades important for neuronal develop-
ment and function [88]. Specifically, a burst of ROS
was found to precede the establishment of neural
polarity in vitro [89], synaptic structural plasticity in
Drosophila [90], synaptic functional plasticity in rat
hippocampus [91] and was implicated in neurogen-
esis in neural stem cells [92]. On the flip side, more is
known about the deleterious role of reactive species.
Increased levels of oxidative protein modification are
often correlated with ageing and neurodegenerative
disease pathology (reviewed in Ref. [93]). A positive
correlation between age and cysteine oxidation
levels was first reported from plasma of healthy
volunteers [94]. In addition, cysteine modification by
ROS/RNS species was linked to dysfunction of
proteins implicated in various neurodegenerative
disorders [93]. First, multiple substrates of S-
nitrosylation seem to be oxidised in multiple neuro-
degenerative disorders including amyotrophic lateral
sclerosis (ALS), Alzheimer's (AD), Huntington's (HD)
and Parkinson's diseases (PD) and are perhaps
indicative of increased oxidation levels rather than
causative in disease (reviewed in Ref. [95]). These
substrates include X-linked inhibitor of apoptosis
protein (XIAP), protein disulphide isomerase (PDI)
and glyceraldehyde-3-phosphade dehydrogenase
(GAPDH) that function in cellular apoptotic, endo-
plasmic reticulum (ER)-stress and energy genera-
tion pathways, respectively.
Second, oxidative modifications can affect pro-
teins demonstrated to participate in disease pathol-
ogy. Oxidative PTMs of tau including intermolecular
disulphide bond formation or Cys glutathionylation
was found to promote formation of paired helical
filaments that underlie the molecular structure of
neurofibrillary tangles that were together with amy-
loid b (ab) plaque deposition identified as patholo-
gical hallmarks of AD [96]. Redox proteomic analysis
of AD patient brain samples also led to identification
of a number of redox-regulated enzymes involved in
glucose oxidation and energy metabolism pathways
[97] the dysfunction of which was previously linked to
AD (reviewed in Ref. [98]). Similarly, oxidative
modification of wild-type superoxide dismutase 1
(SOD1) by sulfenic acid formation on Cys111 residue
can result in SOD1 oligomer and fibril formation and
thus induce apoptosis. This mechanism appears to
be relevant to sporadic ALS as increased levels ofPlease cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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cerebrospinal fluid of ALS patients [99].
Oxidative PTMs were also reported in proteins
genetically linked to familial Parkinson's disease
(PD) that is characterised by selective loss of
dopaminergic neurons in the substantia nigra pars
compacta region of the midbrain [100]. On a
molecular level, the pathology of PD is multifactorial
and includes formation of proteinaceous bodies rich
in alpha-synuclein (a-syn), and mitochondrial dys-
function [100]. Evidence suggests that both mole-
cular pathologies can be affected by ROS. PD onset
and progression seem to correlate with depleted
levels of a nonenzymatic antioxidant, glutathione,
that come hand in hand with increased oxidative
stress modification and dysfunction of proteins
identified in familial forms of PD [93,101]. First,
although a-syn contains no native cysteine residues,
oxidation of a-syn methionine residues on interaction
with dopamine (DA) was found to lead to formation of
DA-a-syn adducts that precede toxic soluble oligo-
mer formation [102]. Second, oxidative modification
of Cys106 residue of DJ-1 to sulfinic acid [103], and
downregulation of DJ-1 expression in response to
oxidative stress [104] both led to aberrant a-syn
aggregation. And finally, two oxidative modifications
of Parkin, S-nitrosylation and sulfonylation were
detected in PD [105e107]. Parkin S-nitrosylation
on exposure to NO was independently shown to
inhibit the E3 ubiquitin ligase activity in cell models
[105,106], although this was preceded by a short-
term increase in activity in one of the studies [105]. In
addition, increased levels of Parkin S-nitrosylation
were detected in brain samples from PD patients
[105,106]. Similarly, Parkin sulphonation on cell
exposure to exogenous H2O2 led to an initial
stimulation of its E3-ubiquitin ligase activity, followed
by a decrease, which authors hypothesise is due to
excessive autoubiquitylation [107]. A decrease in
Parkin activity due to chronic ROS exposure could
thus lead to loss of mitochondrial recycling. These
studies demonstrate that increased levels of oxida-
tive stress could underlie both pathological hall-
marks of PD and provide an explanation for the
selective vulnerability of dopaminergic neurons to
cell death. Importantly, they also highlight another
candidate protein, Parkin, as a ROS-sensitive
regulator of selective autophagy that might show a
similar activity feedback loop that was reported in the
study of ATG3 and ATG7 redox regulation [37].
Autophagy in neuronal health and neurodegen-
eration
The autophagy pathway is spatially tuned in
neuronal cells. Autophagosomes were found to
form in neurites and most travel along the axonal
microtubules to the neuronal soma to fuse with
lysosomes [108]. On a physiological level,chuk, The pROS of Autophagy in Neuronal Health, Journal of
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esis and neuronal development and protect cells
from stress-induced loss of viability [108]. Studies of
healthy ageing and familial neurodegenerative dis-
eases highlight the need for functional autophagy in
the aged brain. Owing to the high levels of ROS/
RNS, yet relatively low level of antioxidants, the
second line of antioxidant defence, including the
proteasome- and autophagy-mediated substrate
degradation, is crucial for redox status maintenance
in the brain and prevention of age-related neurode-
generation [85]. Autophagy impairment has been
reported from studies of postmortem tissue from
patients suffering from neurodegenerative diseases
[109e111] and in healthy aged human brains
[112,113]. The link between functional autophagy
and neuronal health is further supported by a series
of studies focussing on key autophagy genes
involved in the pathway initiation. These demon-
strate that autophagy abolition alone is sufficient to
drive protein aggregation, neuronal death and early-
onset neurodegeneration (reviewed in more detail in
Ref. [114]). In addition to the core autophagy
proteins, dysfunction of or mutations in many
proteins linked to neurodegeneration are now
recognised for their direct (autophagosome forma-
tion, cargo recognition) or indirect (lysosome dys-
function) involvement in the autophagy pathway
[114].
Alterations in autophagy flux in AD were first
observed by electron microscopy imaging of AD
brains [109] and later confirmed in a familial form of
AD, where loss presenilin-1 function leads to
insufficient lysosome acidification, an end-stage
block to autophagy flux and deposition of amyloid
plaques [115]. In addition, low expression levels of
Beclin 1, a member of the class III PI(3)-kinase
complex, were reported from AD patient brain tissue
[110], which was also characterised by increased
amyloid deposition in a mouse model. In addition,
both proteins that are characterised in AD pathology,
Ab and tau, and aggregate in either plaques (Ab) or
tangles (tau), are substrates of autophagy [116,117].
Importantly, amyloid plaques were found to contain a
high amount of zinc, iron and copper metals that can
lead to aberrant ROS production [118] and result in
oxidation of other cellular components. This
sequence of events would support findings from a
model of AD pathology [119], whereby disease
progression is underpinned by age-related autop-
hagy dysfunction that leads to amyloid deposition,
ROS release and exacerbated tau pathology. How-
ever, the role of either hallmark of AD pathology or
indeed their interaction, is still highly disputed and
the sequence of molecular events requires further
study [120].
HD is characterised by trinucleotide repeat expan-
sion in the huntingtin gene that results in a toxic gain
of function of the expressed protein and aberrantPlease cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
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huntingtin is a substrate of autophagy. In addition,
huntingtin was shown to stimulate autophagy in vitro
by potentially acting as a scaffold for selective cargo
recognition (reviewed in Ref. [121]), although the
relevance of the study to an in vivo scenario is
unknown. Interestingly, a common V471A poly-
morphism of ATG7 was identified as a modifier of
HD in heterozygous carriers in German and Italian
populations [123,124]. However, the effect of the
V471A mutation on ATG7 function in autophagy, or
the redox-sensitive Cys572 residue implicated in
autophagy modulation [37], remains unknown.
Familial forms of ALS, the most common form of
motor neuron disease, are among others, linked to
two selective autophagy receptors, p62 and opti-
neurin involved in recognition and clearance of
protein aggregates [125]. The nature of protein
aggregation and an interdependence between
potential dysfunction of selective cargo recognition
and neuronal toxicity in ALS is currently unknown as,
at least in p62 studies, disease-causing mutations
have been identified in multiple regions of the protein
and lack a clear link between the site of mutation and
loss of function [126].
a-Syn mutation or aggregation in PD can affect
autophagy flux in several ways. First, increased a-
syn levels were sufficient to inhibit autophagy in cell
culture and animal models including Drosophila and
mouse [127] by interfering with ATG9 localisation to
the site of autophagosome formation. In addition,
excessive a-syn levels interfered with TFEB translo-
cation to the nucleus and thus impaired expression
of lysosomal and autophagy genes in a rat midbrain
[128]. Moreover, changes in TFEB localisation were
also detected in postmortem brain samples from PD
patients [128]. The clearest link between autophagy
impairment and PD comes from studies of PINK1-
Parkin mediated mitophagy [64,65]. Loss of function
of either protein leads to loss of mitochondrial
recycling in response to depolarisation and auto-
somal recessive onset of PD. Altogether, loss of
proteostasis that presents as aberrant protein
aggregate formation and autophagy impairment is
common to many familial and sporadic forms of
neurodegenerative disease but the exact contribu-
tion of autophagy dysfunction to disease pathology
is not completely understood.
ROS-Autophagy axis in neurodegeneration
Although it is widely recognised that autophagy
dysregulation and increased oxidative stress play a
key role in ageing and underlie many inherited and
spontaneous neurodegenerative diseases, the links
between excessive ROS and autophagy dysfunction
in the human brain remain elusive. The lack of
understanding of the causative relationship in
human neuronal health is underpinned by severalchuk, The pROS of Autophagy in Neuronal Health, Journal of
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sporadic disease are carried out on postmortem
tissue, which can inform about the end state of
disease but not about its progression and the
causality of observed pathology in disease [129].
The use of animal models addressed some of the
problems and enabled researchers to gain insight
into pathological features and biology of disease by
studying transgenic animals and to infer causality by
tissue/cell-type specific mutant protein targeting
[130,131]. However, the extent to which model
animals reconstitute human disease pathology
varies greatly and translation of research findings
from the laboratory to the clinic remains challenging.
Moreover, the multifactorial and varied nature of
dysfunction in sporadic disease combined with the
lack of reliable biomarkers and the difficulty with
obtaining data due to the inaccessibility of brain
tissue complicate the effort of a patient-specific
diagnosis and treatment tailoring. The conflicting
results of crosstalk between ROS and autophagy
complicate the issue on a molecular level. Although
short bursts of ROS tested in cellular and animal
models increase autophagy flux [16,22,23,32], the
effects of chronic exposure to elevated ROS levels,
in some cases combined with a decreased capacity
of the antioxidant system, are unclear. It is currently
widely accepted that ROS activate autophagy as a
cytoprotective feedback mechanism that restores
cellular homeostasis. However, we can only
hypothesise whether chronic ROS formation in the
context of inefficient autophagic flux would have the
same, or an entirely opposite effect.
And finally, no disease-causing genetic mutations
of cysteine residues in autophagy proteins suscep-
tible to oxidative modification have been reported.
The two notable exceptions come from proteins
involved in selective cargo degradation, including
identification of six disease-causing mutations of
redox-sensitive cysteines in Parkin [107] and our
study of the K102E mutation in p62 that is relevant to
a subset of sporadic ALS cases [47]. In the PARK2
gene, disease-causing mutations in Cys212, Cys268,
Cys289 and Cys441 made Parkin more susceptible to
aggregation, often into a single mass, when com-
pared to wild-type or other disease-causing muta-
tions [132]. In this case, loss of mutated Parkin
activity and disease onset occurs likely due to its
sequestration in protein aggregates rather than loss
of redox-sensing activity. By contrast, we have
demonstrated that a missense mutation in the
SQSTM1 gene that is causative in sporadic form of
ALS, the K102E mutation, impaired the formation of
intermolecular disulphide bond formation and, by
extension, reduced the redox sensitivity of p62 [47].
As new discoveries of redox-sensitive proteins
involved in the autophagy pathway are reported
[37,123,124], it will be interesting to see whether
other common polymorphisms in autophagy machin-Please cite this article as: L. Sedlackova, G. Kelly and V. I. Korol
Molecular Biology, https://doi.org/10.1016/j.jmb.2020.01.020ery are identified as redox-sensitive disease modi-
fiers and whether development of targeted therapy
becomes a possibility.Concluding Remarks and Perspectives
Multiple lines of evidence from patient tissue and
animal models implicate autophagy dysfunction in
the onset and progression of neurodegenerative
diseases. Similarly, while low levels of ROS release
may be beneficial as messengers mediating cellular
development and adaptation to stress, chronic
exposure to elevated ROS levels and the resulting
oxidative modification of cysteine residues can
interfere with mitochondrial function, neuronal
synapse and cell survival. The interplay between
autophagy and ROS in healthy cells seems to be
beneficial. Short bursts of ROS mediate autophagy
activation at the level of transcription, protein
enzymatic activity and substrate recognition and
thus create an important link between the need for
degradation of oxidised cellular substrates and the
efficiency of the autophagic pathway. Current
evidence also suggests the presence of a self-
regulatory system by which ROS-mediated inacti-
vation of ATG3 and ATG7 proteins, Parkin auto-
ubiquitylation and increased degradation of p62 via
autophagy prevent excessive cellular catabolism in
response to ROS signals. However, evidence from
ageing and neurodegenerative models indicates
that this regulatory link is broken by either
decreased cellular detoxification due to loss of
autophagic flux, or elevated ROS formation that
overwhelms cellular cytoprotection and leads to the
loss of cell viability. Although the evidence of
autophagy redox-sensitive protein involvement in
neuronal disease pathology is lacking, we hypothe-
sise that chronic ROS exposure highjacks the self-
regulatory autophagy systems, thus promoting a
sustained block in autophagy flux and promotes
establishment of a vicious cycle of toxicity and
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